Biocept
Country
USA
Краткое название
Biocept Inc
Headquarters
5810 Nancy Ridge Drive Suite 150
Members of the board
Bill Kachioff, Senior Vice President of Finance and Chief Financial Officer
Lyle Arnold, Ph.D., Senior Vice-President of Research & Development, Chief Scientific Officer
Farideh Z. Bischoff, Ph.D., Vice-President Translational Research and Clinical Development
Philip D. Cotter, Ph.D., FACMG, Vice President and Director of Clinical Laboratories
Michael Dunn, MBA, Senior Vice President Corporate Development
Kathe Houghtaling, Vice President of Human Resources
Lyle Arnold, Ph.D., Senior Vice-President of Research & Development, Chief Scientific Officer
Farideh Z. Bischoff, Ph.D., Vice-President Translational Research and Clinical Development
Philip D. Cotter, Ph.D., FACMG, Vice President and Director of Clinical Laboratories
Michael Dunn, MBA, Senior Vice President Corporate Development
Kathe Houghtaling, Vice President of Human Resources
Categories medicine
Oncology
Stage of the project
Production
Disease
Brain cancer, Blood cancer, Thyroid and vascular gland cancer, Virilia cancer, Muliebria cancer, Breast cancer, Melanoma, Lung cancer, Intestine cancer, Gastric cancer
Current owners
David Hale, Executive Chairman
Claire K. T. Sung Reiss, Chairperson Emerita
Ed Dennis, PhD
Bruce E. Gerhardt, CPA
Ed Neff
Daniel H. Petree, JD
Ivor Royston, MD
M. Faye Wilson, CPA, MBA; Lead Director
Claire K. T. Sung Reiss, Chairperson Emerita
Ed Dennis, PhD
Bruce E. Gerhardt, CPA
Ed Neff
Daniel H. Petree, JD
Ivor Royston, MD
M. Faye Wilson, CPA, MBA; Lead Director
Technology
Services, Technologies